Anaerostipes hadrus
Selected indexed studies
- Anaerostipes hadrus, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil. (mSphere, 2024) [PMID:38470044]
- Extracellular fructooligosaccharide degradation in Anaerostipes hadrus for co-metabolism with non-fructooligosaccharide utilizers. (Biochem Biophys Res Commun, 2022) [PMID:35537289]
- Gut microbiota dysbiosis promotes cognitive impairment via bile acid metabolism in major depressive disorder. (Transl Psychiatry, 2024) [PMID:39719433]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Anaerostipes hadrus, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil. (2024) pubmed
- Extracellular fructooligosaccharide degradation in Anaerostipes hadrus for co-metabolism with non-fructooligosaccharide utilizers. (2022) pubmed
- Gut microbiota dysbiosis promotes cognitive impairment via bile acid metabolism in major depressive disorder. (2024) pubmed
- Complete Genome Sequence of Anaerostipes hadrus JCM 17467(T). (2023) pubmed
- Global compositional and functional states of the human gut microbiome in health and disease. (2024) pubmed
- Gut microbiota-derived indoleacetic acid attenuates neuroinflammation and neurodegeneration in glaucoma through ahr/rage pathway. (2025) pubmed
- Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial. (2025) pubmed
- Complete genome sequences of butyrate producing Anaerostipes hadrus strains BA1 and GIF7 isolated from the terminal ileum of a healthy lean male. (2023) pubmed
- Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. (2012) pubmed
- Strain-level variation controls nutrient niche occupancy by health-associated Anaerostipes hadrus. (2025) pubmed